Gary K Johnson, MD - Medicare Otolaryngology in Mount Vernon, WA

Gary K Johnson, MD is a medicare enrolled "Otolaryngology" physician in Mount Vernon, Washington. He went to University Of Washington School Of Medicine and graduated in 1974 and has 50 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Public Hospital Dist No 1 Skagit and his current practice location is 118 S 12th St, Mount Vernon, Washington. You can reach out to his office (for appointments etc.) via phone at (360) 336-2178.

Gary K Johnson is licensed to practice in Washington (license number MD00011699) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1437129186.

Contact Information

Gary K Johnson, MD
118 S 12th St,
Mount Vernon, WA 98274-4036
(360) 336-2178
(360) 336-1995



Physician's Profile

Full NameGary K Johnson
GenderMale
SpecialityOtolaryngology
Experience50 Years
Location118 S 12th St, Mount Vernon, Washington
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Gary K Johnson attended and graduated from University Of Washington School Of Medicine in 1974
  NPI Data:
  • NPI Number: 1437129186
  • Provider Enumeration Date: 01/25/2006
  • Last Update Date: 11/02/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 2365336401
  • Enrollment ID: I20100908000252

Medical Identifiers

Medical identifiers for Gary K Johnson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1437129186NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207YS0123XOtolaryngology - Facial Plastic Surgery MD00011699 (Washington)Secondary
207YX0602XOtolaryngology - Otolaryngic Allergy MD00011699 (Washington)Secondary
207YX0905XOtolaryngology - Otolaryngology/facial Plastic Surgery MD00011699 (Washington)Secondary
208200000XPlastic Surgery MD00011699 (Washington)Secondary
2086S0122XSurgery - Plastic And Reconstructive Surgery MD00011699 (Washington)Secondary
207Y00000XOtolaryngology MD00011699 (Washington)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Skagit Valley HospitalMount vernon, WAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Public Hospital Dist No 1 Skagit6800793522248

News Archive

Gene therapy for Parkinson's disease is safe and some patients benefit

A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Dietary induction of hepatocyte regeneration may be a viable strategy to enhance gene repair

Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gary K Johnson allows following entities to bill medicare on his behalf.
Entity NameProliance Surgeons Inc Ps
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023170313
PECOS PAC ID: 8527972900
Enrollment ID: O20031119000128

News Archive

Gene therapy for Parkinson's disease is safe and some patients benefit

A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Dietary induction of hepatocyte regeneration may be a viable strategy to enhance gene repair

Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.

Read more Medical News

› Verified 3 days ago

Entity NamePublic Hospital Dist No 1 Skagit
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023332749
PECOS PAC ID: 6800793522
Enrollment ID: O20040309001059

News Archive

Gene therapy for Parkinson's disease is safe and some patients benefit

A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Dietary induction of hepatocyte regeneration may be a viable strategy to enhance gene repair

Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gary K Johnson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gary K Johnson, MD
1400 E Kincaid St,
Mount Vernon, WA 98274-4127

Ph: (360) 336-2178
Gary K Johnson, MD
118 S 12th St,
Mount Vernon, WA 98274-4036

Ph: (360) 336-2178

News Archive

Gene therapy for Parkinson's disease is safe and some patients benefit

A novel gene therapy technique is safe and may be effective at staving off worsening symptoms of Parkinson's disease, according to the first scientific review of a dozen patients who have received the treatment over the last three years.

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Dietary induction of hepatocyte regeneration may be a viable strategy to enhance gene repair

Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver.

Read more News

› Verified 3 days ago


Otolaryngology Doctors in Mount Vernon, WA

James R Gross, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 118 S 12th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-1995
Dr. Christopher Ray England, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 118 S 12th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-1995
Dr. Michael Bryan Mullen, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 118 S 12th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-1995
Gary L Brown, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 118 S 12th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-1995
Dr. Jonathan R Grant, MD
Otolaryngology
Medicare: May Accept Medicare Assignments
Practice Location: 111 S 13th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-1674
Dr. Anna Jane Knisely, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 111 S 13th St, Mount Vernon, WA 98274
Phone: 360-336-2178    Fax: 360-336-2642

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.